Medical Biotechnology — Predicted 2026

AI-Predicted Question Angles for UPSC 2026

Based on trend analysis, current affairs, and recurring themes in Medical Biotechnology.

Ethical and Regulatory Framework for Gene Editing in India

High

With global advancements in CRISPR and discussions around its clinical application, particularly for genetic disorders prevalent in India (like sickle cell anemia), UPSC is likely to probe the ethical considerations (germline vs. somatic, off-target effects, 'designer babies') and the evolving regulatory landscape in India. Questions could focus on ICMR guidelines, the role of ethical committees, and the balance between innovation and safety. The recent CAR-T approval sets a precedent for advanced therapies, making gene editing a natural follow-up.

Medical Biotechnology's Role in Achieving Health-related Sustainable Development Goals (SDGs) in India

Medium to High

UPSC frequently links scientific advancements to broader national and international goals. Medical biotechnology's contributions to disease prevention (vaccines), diagnosis (molecular diagnostics), and treatment (therapeutics, personalized medicine) directly align with SDG 3 (Good Health and Well-being). Questions could explore how India leverages biotech for affordable healthcare, reducing disease burden, and improving maternal/child health, linking to government schemes and indigenous R&D efforts.

The Impact of Biosimilars and Indigenous Biologics on Healthcare Affordability and Access in India

High

India's leadership in biosimilars and the 'Make in India' push in pharmaceuticals are significant. UPSC could ask about the economic implications of biosimilars, their role in reducing healthcare costs, challenges in their development and market penetration, and how they contribute to equitable access to advanced therapies for chronic diseases. The success stories of Indian companies like Biocon will be central to such questions.